Savillex, LLC has completed its acquisition of Entegris, Inc.’s Life Sciences Fluid Management business, the Eden Prairie, Minn.-based fluid-handling specialist said. The acquired portfolio covers bioprocessing and pharmaceutical manufacturing, including Aramus and PE bags, single-use assemblies and components used in discovery, clinical and commercial production.
Entegris is based in Billerica, Mass. Savillex said the addition broadens its life sciences offering with more high-performance single-use products. The company also gains the acquired unit’s fluid-management team and technologies, which it expects to combine with its existing Savillex, Containment and Bioprocessing offerings. Customers are expected to have access to a wider set of single-use solutions and greater technical expertise across work from early research to commercial manufacturing.
Eric Giesing, chief executive officer of Savillex, said the acquired business had established a strong reputation in high-purity single-use bioprocessing and that the Aramus line fits naturally with Savillex’s existing portfolio. He said the transaction expands the company’s offerings and is intended to let it serve biopharmaceutical and pharmaceutical customers with a broader range of solutions, while continuing to invest in technologies intended to help customers accelerate development and production of critical therapies.
Chris Bedi, general manager of fluid management at Savillex, said the combined portfolio complements Savillex’s capabilities and is meant to extend support for partners throughout drug development.
Savillex described the acquisition as part of a strategy to provide industry-leading life sciences solutions and to keep investing in innovation, quality and customer partnerships. Financial terms were not disclosed. EC M&A advised Savillex, and Sidley Austin LLP provided legal counsel.